JP2012504948A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012504948A5 JP2012504948A5 JP2011530513A JP2011530513A JP2012504948A5 JP 2012504948 A5 JP2012504948 A5 JP 2012504948A5 JP 2011530513 A JP2011530513 A JP 2011530513A JP 2011530513 A JP2011530513 A JP 2011530513A JP 2012504948 A5 JP2012504948 A5 JP 2012504948A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- epithelial cells
- pharmaceutical composition
- osm
- diseases caused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002919 epithelial cell Anatomy 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 102000004140 Oncostatin M Human genes 0.000 claims 10
- 108090000630 Oncostatin M Proteins 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 244000052769 pathogen Species 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 210000004027 cell Anatomy 0.000 claims 7
- 230000001413 cellular effect Effects 0.000 claims 7
- 241000233866 Fungi Species 0.000 claims 6
- 239000013604 expression vector Substances 0.000 claims 6
- 244000045947 parasite Species 0.000 claims 6
- 238000003259 recombinant expression Methods 0.000 claims 6
- 241000894006 Bacteria Species 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 239000012678 infectious agent Substances 0.000 claims 5
- 210000004698 lymphocyte Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 230000001717 pathogenic effect Effects 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 102000002227 Interferon Type I Human genes 0.000 claims 2
- 108010014726 Interferon Type I Proteins 0.000 claims 2
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 2
- 239000003183 carcinogenic agent Substances 0.000 claims 2
- 210000000981 epithelium Anatomy 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 claims 1
- 102100040019 Interferon alpha-1/13 Human genes 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000003501 co-culture Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 210000002751 lymph Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000005087 mononuclear cell Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200802835 | 2008-10-07 | ||
| ES200802835A ES2342529B1 (es) | 2008-10-07 | 2008-10-07 | Oncostatina m como potenciador de la actividad inmunoestimuladora de celulas epiteliales humanas. |
| PCT/ES2009/070419 WO2010040882A1 (es) | 2008-10-07 | 2009-10-06 | Oncostatina m como potenciador de la actividad inmunoestimuladora de células epiteliales humanas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012504948A JP2012504948A (ja) | 2012-03-01 |
| JP2012504948A5 true JP2012504948A5 (OSRAM) | 2012-11-22 |
Family
ID=41478601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011530513A Pending JP2012504948A (ja) | 2008-10-07 | 2009-10-06 | ヒト上皮細胞の免疫賦活活性の増強剤としてのオンコスタチンｍ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110195047A1 (OSRAM) |
| EP (1) | EP2345423A1 (OSRAM) |
| JP (1) | JP2012504948A (OSRAM) |
| CN (1) | CN102202690A (OSRAM) |
| AU (1) | AU2009301067A1 (OSRAM) |
| BR (1) | BRPI0920662A2 (OSRAM) |
| CA (1) | CA2739670A1 (OSRAM) |
| ES (1) | ES2342529B1 (OSRAM) |
| MX (1) | MX2011003676A (OSRAM) |
| RU (1) | RU2011118362A (OSRAM) |
| WO (1) | WO2010040882A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102352368B (zh) * | 2011-09-29 | 2013-12-04 | 苏州大学 | Ing4与osm双基因共表达载体及其应用 |
| US20130330761A1 (en) | 2012-06-12 | 2013-12-12 | Celcuity, LLC | Whole cell assays and methods |
| EP3015864A4 (en) * | 2013-06-14 | 2017-01-18 | Universidad de Granada | Biomarkers for the diagnosis and the response to treatment of pancreatic cancer |
| WO2015089380A2 (en) * | 2013-12-12 | 2015-06-18 | Celcuity Llc | Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent |
| CN104096219A (zh) * | 2014-07-08 | 2014-10-15 | 武汉大学 | Ⅱ型抑瘤素m受体（osmr）在治疗脂肪肝和ⅱ型糖尿病中的功能和应用 |
| KR20220165826A (ko) | 2017-03-20 | 2022-12-15 | 셀퀴티 인크. | 치료제의 선택을 위한 신호전달 경로 활성을 측정하는 방법 |
| IL302147A (en) | 2020-10-19 | 2023-06-01 | Zoetis Services Llc | Antibodies to the oncostatin M cell receptor of dogs and cats and their uses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| IL112767A (en) | 1989-04-10 | 1998-01-04 | Oncogen | Pharmaceutical compositions containing oncostatin m |
| US7115261B1 (en) * | 1999-02-12 | 2006-10-03 | The Scripps Research Institute | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| AU2001288863A1 (en) * | 2000-09-15 | 2002-03-26 | Ortho-Mcneil Pharmaceutical, Inc. | Compositions and methods for inducing specific cytolytic t cell responses |
| JP2004026768A (ja) | 2002-06-27 | 2004-01-29 | Kanagawa Acad Of Sci & Technol | 肝疾患治療又は予防薬 |
| AU2002953238A0 (en) * | 2002-12-09 | 2003-01-02 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | In vitro immunization |
| US7740861B2 (en) * | 2004-06-16 | 2010-06-22 | University Of Massachusetts | Drug delivery product and methods |
| JP2008526889A (ja) * | 2005-01-10 | 2008-07-24 | リサーチ ディベロップメント ファウンデーション | 癌治療のための標的化キメラ分子 |
| CA2597171A1 (en) | 2005-02-03 | 2006-08-10 | Raven Biotechnologies, Inc. | Antibodies to oncostatin m receptor |
| ES2302402B1 (es) * | 2005-06-16 | 2009-05-08 | Proyecto De Biomedicina Cima, S.L. | Uso de una citoquina de la familia de interleuquina-6 en la preparacion de una composicion para administracion combinada con interferon-alfa. |
-
2008
- 2008-10-07 ES ES200802835A patent/ES2342529B1/es not_active Withdrawn - After Issue
-
2009
- 2009-10-06 MX MX2011003676A patent/MX2011003676A/es active IP Right Grant
- 2009-10-06 JP JP2011530513A patent/JP2012504948A/ja active Pending
- 2009-10-06 BR BRPI0920662-0A patent/BRPI0920662A2/pt not_active IP Right Cessation
- 2009-10-06 US US13/123,031 patent/US20110195047A1/en not_active Abandoned
- 2009-10-06 WO PCT/ES2009/070419 patent/WO2010040882A1/es not_active Ceased
- 2009-10-06 CA CA2739670A patent/CA2739670A1/en not_active Abandoned
- 2009-10-06 RU RU2011118362/10A patent/RU2011118362A/ru unknown
- 2009-10-06 AU AU2009301067A patent/AU2009301067A1/en not_active Abandoned
- 2009-10-06 CN CN2009801443381A patent/CN102202690A/zh active Pending
- 2009-10-06 EP EP09755922A patent/EP2345423A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012504948A5 (OSRAM) | ||
| ES2380796T3 (es) | Oligonucleótidos inmunoestimuladores y sus usos. | |
| Lu et al. | The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B | |
| JP2004536615A5 (OSRAM) | ||
| UA85371C2 (ru) | Модифицированный вирус коровьей оспы ankara для вакцинации новорожденных | |
| Zhang et al. | Effects of astragalus polysaccharide on the immune response to foot-and-mouth disease vaccine in mice | |
| JP2017533920A (ja) | ウイルス粒子を用いた癌免疫療法 | |
| US20200360497A1 (en) | Compositions and methods for producing dendritic cells | |
| JP2012515213A5 (OSRAM) | ||
| Dong et al. | Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice | |
| BR0316758A (pt) | Vacinas baseadas em levedura como imunoterapia | |
| JP2019520061A5 (OSRAM) | ||
| Liu et al. | Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK) | |
| RU2011118362A (ru) | Онкостатин как усилитель иммуностимулирующей активности человеческих эпителиальных клеток | |
| CN111787931A (zh) | 分离的赤红球菌细胞壁骨架在制备治疗人乳头瘤病毒感染的药物中的用途 | |
| Kowalczewska et al. | Polysaccharide peptides from Coriolus versicolor exert differential immunomodulatory effects on blood lymphocytes and breast cancer cell line MCF-7 in vitro | |
| CN107488235A (zh) | 一种新的增强型抗原联合多肽诱导肝癌特异性ctl细胞的制备及应用 | |
| Sangeetha Vijayan et al. | A review of immune modulators and immunotherapy in infectious diseases | |
| Geng et al. | Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells | |
| US7776324B2 (en) | Cancer vaccine | |
| Jia et al. | Structural, phenotypic and functional maturation of bone marrow dendritic cells (BMDCs) induced by Chitosan (CTS) | |
| CN102793914A (zh) | 一种新型血管内皮细胞疫苗及其制备方法 | |
| CN119523963B (zh) | 一种杂萜类化合物的医药用途 | |
| WO2011114346A1 (en) | Chitin and related compounds for use in treating bacterial and viral infections | |
| Liang et al. | Aggregation-Induced Emission-Based Vaccine Improves Potential Antitumor Immunotherapy |